{"id":717319,"date":"2024-10-17T18:20:02","date_gmt":"2024-10-17T18:20:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=717319"},"modified":"2024-10-17T18:20:02","modified_gmt":"2024-10-17T18:20:02","slug":"increasing-outsourcing-of-rd-activities-aids-contract-research-organization-market-to-achieve-cagr-of-95-by-2031","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/increasing-outsourcing-of-rd-activities-aids-contract-research-organization-market-to-achieve-cagr-of-95-by-2031_717319.html","title":{"rendered":"Increasing Outsourcing of R&D Activities Aids Contract Research Organization Market to Achieve CAGR of 9.5% by 2031"},"content":{"rendered":"
\n
\"Increasing<\/a><\/div>\n
\n
Contract Research Organization Market<\/div>\n<\/div>\n<\/div>\n
Contract Research Organization Market size was valued at around USD 68 billion in 2022 and is expected to rise from USD 75.1 billion in 2023 to reach a value of USD 155.2 billion by 2031, at a CAGR of 9.5% over the forecast period (2024\u20132031).<\/div>\n

The contract research organization market<\/strong><\/a> is growing at a significant level due to various important reasons. Majorly, CROs provide various R&D services to pharmaceutical, biotechnology, and medical device companies that include clinical trials, regulatory affairs, data administration, etc. Pharmaceutical companies are increasingly outsourcing their research work to other market organizations because of a demand for specialized knowledge, cost cutting, and reducing the time it takes to get new drugs. In addition, the growing complexity of clinical trials and the increasing need for tailored medication drive demand for CRO services. Growth drivers for expanded market growth include a growing biopharmaceutical pipeline and significant and ongoing outsourcing by small and mid-sized businesses.<\/p>\n

Request your free sample PDF of the report today<\/strong>: https:\/\/www.skyquestt.com\/sample-request\/contract-research-organization-market<\/a><\/p>\n

Role of R&D Investment in Advancing Medical Solutions<\/strong><\/p>\n

Pharmaceutical, biotechnology, and medical device companies have drastically upped their efforts on R&D investment due to the persistent demand for effective diagnosis and treatments. This boom is the main reason for this heightened number of clinical trials going on globally today; it allowed businesses to innovate and produce novel medicines much more quickly. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA) has reported expenditure by pharmaceutical companies on R&D, where a 7.2% increase in 2022 brought it to an impressive USD 46,792.8 million. The trend just speaks of how eager the industry is for health solutions and how important it is to keep funding research and come up with new medical breakthroughs for the future.<\/p>\n

For a tailored report, contact us to request a free customization<\/strong>:  https:\/\/www.skyquestt.com\/speak-with-analyst\/contract-research-organization-market<\/a><\/p>\n

Evolving Competitive Landscape of Contract Research Organizations<\/strong><\/p>\n

The contract research organization market is characterized by the presence of established and new companies. With the objective of business expansion, efficiency, and performance improvement in contract research organizations, participants in this market are paying extra attention to R&D projects. Furthermore, companies tend to make use of strategic alliances, partnerships, mergers, and acquisitions to expand their market presence. Government laws, in addition to the capacity to deliver sustainable and affordable solutions and technical breakthroughs, shape the competitive landscape.<\/p>\n

Key Moves of Market Players<\/strong><\/p>\n

In January 2023, a strategic alliance was announced with the leading clinical research organization, AlphaCRO, and cutting-edge technology business BioPharm Innovations, specializing in clinical trial management systems.<\/p>\n

In March 2023, the renowned CRO NovaResearch opened a new office to meet the rising demand for clinical research services in the Asia-Pacific region.<\/p>\n

In June 2023, a novel genomics company and MedTrials-a top CRO specializing in clinical research-have formed a strategic alliance for enabling precision medicine trials.<\/p>\n

This report covers following segments:<\/strong><\/p>\n

A. Application<\/strong><\/p>\n

Clinical Research Services ( Phase (Phase III, Phase II, Phase I, Phase IV), By Study Design (For Phase III & IV) (Interventional, Real World Evidence (RWE))<\/p>\n

Early phase development Services (Chemistry, Manufacturing and Controls Services, Preclinical Services (Pharmacokinetics\/ Pharmacodynamics Services, Toxicology Testing Services, Other Preclinical Services), Discovery Studies)<\/p>\n

Laboratory Services (Analytical Testing Services (Physical Characterization Services, Raw Material Testing Services, Batch Release Testing Services, Stability Testing Services, Other Analytical Testing Services), Bioanalytical Testing Services)<\/p>\n

Consulting Services<\/p>\n

Data Management Services<\/p>\n

B. Therapeutic Area<\/strong><\/p>\n

Oncology (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Cancer)<\/p>\n

Infectious Diseases<\/p>\n

CVS Disorders<\/p>\n

Neurology<\/p>\n

Vaccines, Metabolic Disorders\/Endocrinology<\/p>\n

Immunological Disorders<\/p>\n

Psychiatry<\/p>\n

Respiratory Disorders<\/p>\n

Dermatology<\/p>\n

Ophthalmology<\/p>\n

Gastrointestinal Diseases<\/p>\n

Genitourinary & Women’s Health<\/p>\n

Hematology<\/p>\n

Other Therapeutic Areas.<\/p>\n

C. End User<\/strong><\/p>\n

Pharmaceutical & Biopharmaceutical Companies<\/p>\n

Medical Device Companies<\/p>\n

Academic Institutes<\/p>\n

This report covers following players:<\/strong><\/p>\n

IQVIA <\/p>\n

Laboratory Corporation of America Holdings (Labcorp) <\/p>\n

PPD Inc. (a part of Thermo Fisher Scientific, Inc.) <\/p>\n

Syneos Health Inc. <\/p>\n

WuXi AppTec Co., Ltd. <\/p>\n

Charles River Laboratories International, Inc. <\/p>\n

Parexel International Corporation <\/p>\n

Pharmaron Beijing Co., Ltd. <\/p>\n

ICON PLC <\/p>\n

Medpace Holdings, Inc. <\/p>\n

SGS SA <\/p>\n

Frontage Holdings Corporation <\/p>\n

PSI CRO AG <\/p>\n

BioAgile Therapeutics Pvt. Ltd. <\/p>\n

Firma Clinical Research, LLC <\/p>\n

AccuLab Life Sciences <\/p>\n

Novotech Health Holdings <\/p>\n

KCR (formerly Kiecana Clinical Research) <\/p>\n

Linical Co., Ltd. <\/p>\n

Advanced Clinical <\/p>\n

Azelix LLC <\/p>\n

Clinical Trial Service BV <\/p>\n

Pepgra Healthcare Pvt. Ltd. <\/p>\n

Worldwide Clinical Trials Holdings Inc. <\/p>\n

CTI Clinical Trial and Consulting Services, Inc.<\/p>\n

Purchase now to gain valuable insights and stay informed<\/strong>: https:\/\/www.skyquestt.com\/buy-now\/contract-research-organization-market<\/a><\/p>\n

Future of Contract Research Organizations in Drug Development<\/strong><\/p>\n

The pharmaceutical, biotechnology, and medical device industries rely heavily on contract research services, and in this regard, the global contract research organization market is surface as a fast-growing market. For all their customers, CROs come in as essential contributors in managing clinical trials, in the development of new drugs, and in meeting regulations. This is supported by several factors such as an increase in R&D, cheaper solutions, knowledge of specialization, and a faster speed of taking products to the markets.<\/p>\n

To read the full report, please visit<\/strong>: https:\/\/www.skyquestt.com\/report\/contract-research-organization-market<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Skyquest Technology<\/a>
Contact Person:<\/strong> Mr. Jagraj Singh
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 351-333-4748
Address:<\/strong>1 Apache Way, Westford,
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.skyquestt.com\/report\/contract-research-organization-market<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Contract Research Organization Market Contract Research Organization Market size was valued at around USD 68 billion in 2022 and is expected to rise from USD 75.1 billion in 2023 to reach a value of USD 155.2 billion by 2031, at … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,403,404],"tags":[],"class_list":["post-717319","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/717319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=717319"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/717319\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=717319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=717319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=717319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}